Clinical trial
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck…
NCT00198328 · Inovio Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00198328 |
|---|---|
| Title | Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma |
| Official title | A Randomized Trial Comparing Preservation of Function Status After Either Medpulser Electroporation With Intratumoral Bleomycin Therapy or Surgery in Patients With Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Base of the Tongue, Posterior Lateral Pharyngeal Wall, Hypopharynx… |
| Lead sponsor | Inovio Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head Neck Cancer |
| Intervention type | Combination Product, Procedure |
| Interventions | Medpulser Electroporation with Bleomycin, Surgical Excision |
| Enrollment | 84 |
| Start date | Nov 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 4, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: